Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:1016-1025
Published online before print March 15, 2007, doi: 10.1161/01.RES.0000263381.83835.7b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v102,pe53)
Right arrow All Versions of this Article:
100/7/1016    most recent
01.RES.0000263381.83835.7bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bendall, J. K.
Right arrow Articles by Channon, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bendall, J. K.
Right arrow Articles by Channon, K. M.
Related Collections
Right arrow Animal models of human disease
Right arrow Hypertension - basic studies
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2007;100:1016.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II

Studies in Endothelial-Targeted Nox2 Transgenic Mice

Jennifer K. Bendall, Ruth Rinze, David Adlam, Amy L. Tatham, Joe de Bono, Keith M. Channon

From the Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, OX39DU, UK.

Correspondence to Prof Keith M. Channon, Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK. E-mail keith.channon{at}cardiov.ox.ac.uk

Vascular disease states are associated with endothelial dysfunction and increased production of reactive oxygen species (ROS) derived from vascular NADPH oxidases in both vascular smooth muscle cells (VSMCs) and endothelial cells. Recent evidence suggests an important role for VSMC NADPH oxidases in vascular ROS production. However, it is unclear whether increased NADPH oxidase activity in endothelial cells alone is sufficient to alter overall vascular ROS production and hemodynamics. We sought to address these questions using transgenic mice with endothelial-targeted overexpression of the catalytic subunit of NADPH oxidase, Nox2. Aortas of Nox2 transgenic (Nox2-Tg) mice had increased total Nox2 mRNA and protein levels compared with wild-type littermates. Both p22phox mRNA and protein levels were also significantly elevated in Nox2-Tg aortas. Aortic superoxide production was significantly increased in Nox2-Tg mice compared with wild-type, but this difference was abolished by endothelial removal. Superoxide dismutase inhibition increased superoxide release and levels of Mn superoxide dismutase protein were significantly elevated in aortas from Nox2-Tg mice compared with wild type. Increased ROS production from endothelial Nox2 overexpression led to increased endothelial nitric oxide synthase protein and extracellular signal-regulated kinase 1/2 phosphorylation in transgenic aortas. Basal blood pressure was similar, however the pressor responses to both acute and chronic angiotensin II administration were significantly increased in Nox2-Tg mice compared with wild type. These results demonstrate that endothelial-targeted Nox2 overexpression is sufficient to increase vascular NADPH oxidase activity, activate downstream signaling pathways, and potentiate the hemodynamic response to angiotensin II, despite compensatory increases in vascular antioxidant enzymes. Endothelial cell Nox2-containing NADPH oxidase plays an important functional role in vascular redox signaling.


Key Words: NADPH oxidase • oxidative stress • endothelium • hemodynamics




This article has been cited by other articles:


Home page
CirculationHome page
F. Violi, V. Sanguigni, R. Carnevale, A. Plebani, P. Rossi, A. Finocchi, C. Pignata, D. De Mattia, B. Martire, M. C. Pietrogrande, et al.
Hereditary Deficiency of gp91phox Is Associated With Enhanced Arterial Dilatation: Results of a Multicenter Study
Circulation, October 20, 2009; 120(16): 1616 - 1622.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Wang and Z. Sun
Klotho Gene Delivery Prevents the Progression of Spontaneous Hypertension and Renal Damage
Hypertension, October 1, 2009; 54(4): 810 - 817.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs
Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction
Hypertension, November 1, 2007; 50(5): 919 - 925.
[Abstract] [Full Text] [PDF]